Paradigm Biopharmaceuticals Stock

Paradigm Biopharmaceuticals EBIT Margin

The EBIT Margin (Operating Margin) of Paradigm Biopharmaceuticals (PAR.AX) as of Aug 23, 2026 is -228.51 %. In the previous year, EBIT Margin (Operating Margin) was -910.70 % — a change of -74.91% (higher).

EBIT Margin

-228.51 %

YoY

-74.91%

Last updated:

EBIT Margin (Operating Margin) of Paradigm Biopharmaceuticals is 2026 -228.51 % . EBIT Margin (Operating Margin) of Paradigm Biopharmaceuticals was 2025 -910.70 % . It decreases by -74.91% higher compared to the previous year.

Paradigm Biopharmaceuticals's operating (EBIT) margin stands at -228.5%, up from -403.6% several years earlier.

The Paradigm Biopharmaceuticals EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
-226.22 AUD
Jan 1, 2019
-268.01 AUD
Jan 1, 2020
-265.09 AUD
Jan 1, 2021
-403.60 AUD
Jan 1, 2022
-508.20 AUD
Jan 1, 2023
-607.59 AUD
Jan 1, 2024
-910.70 AUD
Jan 1, 2025
-228.51 AUD
The Paradigm Biopharmaceuticals EBIT Margin history
YEAREBIT MarginYoY
-228.51 %-74.91%
-910.70 %+49.89%
-607.59 %+19.56%
-508.20 %+25.92%
-403.60 %+52.25%
-265.09 %-1.09%
-268.01 %+18.48%
-226.22 %-2.17%
-231.25 %+10.25%
-209.75 %-99.02%
-21,442.47 %—
Access this data via the Eulerpool API
Get Free API Key

Paradigm Biopharmaceuticals Stock analysis

What does Paradigm Biopharmaceuticals do? Paradigm Biopharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Paradigm Biopharmaceuticals stock

EBIT Margin (Operating Margin) of Paradigm Biopharmaceuticals is -228.51 % in 2026.

EBIT Margin (Operating Margin) of Paradigm Biopharmaceuticals changed from -910.70 % to -228.51 %, representing a -74.91% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Paradigm Biopharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Paradigm Biopharmaceuticals with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API
Get Free API Key

Margins — Paradigm Biopharmaceuticals

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Paradigm Biopharmaceuticals